Results 111 to 120 of about 3,244,747 (295)

Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias   +3 more
wiley   +1 more source

Global Rather Than Vertical‐Selective Saccadic Abnormalities in Progressive Supranuclear Palsy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To test whether vertical saccades are preferentially affected in Progressive Supranuclear Palsy (PSP). Methods PSP patients (n = 24) were compared to age‐matched controls (n = 94) and two degenerative groups (Alzheimer's disease, n = 20; Lewy body disease, n = 50).
Duy Duan Nguyen   +6 more
wiley   +1 more source

Connected speech profiles in Mild Cognitive Impairment reflect global cognition

open access: yes
Description of extracted Connected Speech characteristics and code used for the extraction of these characteristics ''Connected speech profiles in Mild Cognitive Impairment reflect global cognition (Under Review)''
Sophie Pellerin, Christophe Bedetti
core   +2 more sources

Cognitive profiles in obstructive sleep apnea: A cluster analysis in sleep clinic and community samples

open access: yes, 2020
Cognitive profiles in obstructive sleep apnea: A cluster analysis in sleep clinic and community ...
D Hillman (13371468)   +8 more
core  

Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali   +4 more
wiley   +1 more source

Multidimensional health profiles and cognitive function of community-dwelling older adults: a latent profile analysis

open access: yesBMC Geriatrics
Background Older adults often experience complex, co-occurring physical, psychological, and social health conditions that together characterize their multidimensional health and may have implications for cognitive function. However, the patterns of these
Myungji Kim, Da Eun Kim
doaj   +1 more source

The cognitive profile of ALS

open access: yesJournal of neurology, neurosurgery, and psychiatry, 2016
Cognitive impairment is present in approximately 30% of patients with amyotrophic lateral sclerosis (ALS) and, especially when severe, has a negative impact on survival and caregiver burden. Our 2010 meta-analysis of the cognitive profile of ALS showed impairment of fluency, executive function, language and memory.
Beeldman, Emma   +5 more
openaire   +1 more source

Cognitive Profiles In Alzheimer’s Disease and In Mild Cognitive Impairment Of Different Etiologies

open access: yes, 2006
There has been increasing interest in determining whether amnestic, nonamnestic and multiple-domain subtypes of mild cognitive impairment (MCI) reflect different disease etiologies.
STRAUMAN, Silvia   +11 more
core   +1 more source

Region Specific miRNA–mRNA Networks in Gray and White Matter Lesions of Progressive Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Multiple sclerosis (MS) is a neurodegenerative demyelinating disease of the central nervous system. This study aimed to identify micro‐RNA (miRNA)–mRNA regulatory networks underlying region‐specific molecular mechanisms in white matter and gray matter lesions in progressive MS.
Adya Sapra   +5 more
wiley   +1 more source

Stage‐Dependent β‐Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Synaptic degeneration drives cognitive decline in Alzheimer's disease (AD), but synaptic biomarkers are scarce. Brain‐enriched β‐synuclein emerged as a synaptic damage marker. We investigated its diagnostic, prognostic, and structural correlates across the AD continuum.
Ulaş Ay   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy